Hypersensitization of tumor cells to glycolytic inhibitors

Biochemistry

Volumn 40, Issue 18, 2001, Pages 5542-5547

  Liu, H ^a   Hu, Y P ^a   Savaraj, N ^a   Priebe, W ^b   Lampidis, T J ^a,c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; COMPLEXATION; GROWTH KINETICS; IRRADIATION; METABOLISM; TUMORS;

HYPERSENSITIZATION;

BIOCHEMISTRY;

ANTIMYCIN A1; ANTINEOPLASTIC AGENT; DEOXYGLUCOSE; GLYCOLYTIC INHIBITOR; LACTIC ACID; OLIGOMYCIN; OXAMIC ACID; RHODAMINE 123; ROTENONE; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOSARCOMA CELL; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SENSITIZATION; TUMOR CELL; TUMOR GROWTH;

ANAEROBIOSIS; ANTIMYCIN A; CULTURE MEDIA; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GLUCOSE; GLYCOLYSIS; GROWTH INHIBITORS; HUMANS; LACTIC ACID; OLIGOMYCINS; OSTEOSARCOMA; OXAMIC ACID; OXIDATIVE PHOSPHORYLATION; RHODAMINE 123; ROTENONE; TUMOR CELLS, CULTURED; UNCOUPLING AGENTS;

EID: 0035826677     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi002426w     Document Type: Article

References (23)

1. Warburg, O., Wind, F., and Negalein, E. (1927) J. Physiol. 8, 519-530.
2. Brown, J. (1962) Metabolism 11, 1098-1112.
3. Hendrikse, N. H. (2000) Curr. Pharm. Des. 6, 1653-1668.
4. Kuwano, M., Toh, S., Uchiumi, H., Kohno, K., and Wada, M. (1999) Anticancer Drug Des. 14, 123-131.
5. Fortune, J. M., and Osheroff, N. (2000) Prog. Nucleic Acid Res. Mol. Biol. 64, 221-253.
6. Reed, J. C. (1995) Hematol./Oncol. Clin. N. Am. 9, 451-474.
7. King, M. P., and Attardi, G. (1989) Science 244, 500-503.
8. Hofhaus, G., Shakeley, R. M., and Attardi, G. (1996) Methods Enzymol. 264, 476-483.
9. Lampidis, T. J., Salet, C., Moreno, G., and Chen, L. B. (1984) AgentsActions 14, 751-757.
10. Modica-Napolitano, J. S., Weiss, M. J., Chen, L. B., and Aprille, J. R. (1984) Biochem. Biophys. Res. Commun. 118, 717-723.
11. Hu, Y. P., Moraes, C., Savaraj, N., Priebe, W., and Lampidis, T. J. (2000) Biochem. Pharmacol. (in press).
12. Buchet, K., and Godinot, C. (1998) J. Biol. Chem. 273, 22983-22989.
13. Barrientos, A., and Moraes, C. T. (1999) J. Biol. Chem. 274, 16188-16197.
14. Thomlinson, R. H., and Gray, L. H. (1955) Br. J. Cancer 9, 539-549.
15. Overgaard, J., and Horsman, M. R. (1996) Semin. Radiat. Oncol. 6, 10-21.
16. Dewhirst, M. W., Ong, E. T. Rosner, G. L., Rhemus, S., Shan, S., Braun, R., Brizel, D., and Secomb, T. (1996) Br. J. Cancer 74 (Suppl. 37), S241-S246.
17. Haroon, Z., Peters, K. G., Greenberg, C. S., and Dewhirst, M. W. (1999) in Antiangiogenic Agents in Cancer Therapy (Teicher, B. D., Ed.) pp 3-22, Humana Press Inc., Totowa, NJ.
18. Aisenberg, A. C. (1961) in The Glycolysis and Respiration of Tumors, pp 56-61, Academic Press, New York.
19. Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Snager, F., Schreier, P. H., Smith, A. J. H., Staden, R., and Young, I. G. (1981) Nature 290, 457-465.
20. Attardi, G., and Schatz, G. (1988) Annu. Rev. Cell Biol. 4, 289-333.
21. Johnson, L. V., Walsh, M. L., Bockus, B. J., and Chen, L. B. (1981) J. Cell Biol. 88, 526-535.
22. Lampidis, T. J., Bernal, S. D., Summerhayes, I. C., and Chen, L. B. (1983) Cancer Res. 43, 716-720.
23. Bernal, S. D., Lampidis, T. J., McIsac, R. M., and Chen, L. B. (1983) Science 222, 169-172.